<DOC>
	<DOCNO>NCT00567203</DOCNO>
	<brief_summary>The objective study evaluate safety , tolerability , efficacy two dose regimen PF-3463275 compare placebo add ongoing atypical antipsychotic therapy cognitive deficit subject chronic symptom schizophrenia .</brief_summary>
	<brief_title>A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Diagnosis schizophrenia In stable treatment risperidone , olanzapine , quetiapine , ziprasidone , aripiprazole , paliperidone least 2 month Stable symptom schizophrenia least 3 month . Subjects psychiatric disorder schizophrenia Substance dependence abuse Women child bear potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>